J
Jun Ma
Researcher at Harbin Institute of Technology
Publications - 1523
Citations - 58397
Jun Ma is an academic researcher from Harbin Institute of Technology. The author has contributed to research in topics: Nasopharyngeal carcinoma & Medicine. The author has an hindex of 97, co-authored 1338 publications receiving 39643 citations. Previous affiliations of Jun Ma include Shenyang Aerospace University & University of Technology, Sydney.
Papers
More filters
Journal ArticleDOI
Influencing investigation of metal ions on heterogeneous catalytic ozonation by ceramic honeycomb for the degradation of nitrobenzene in aqueous solution with neutral pH
TL;DR: In this paper, the influence of metal ions on heterogeneous catalytic ozonation by ceramic honeycomb for degradation of nitrobenzene in aqueous solution was investigated through the semi-continuous batch experiments to compare apparent reaction rate constant (kapp) and hydroxyl radical (OH) formation rate (k · OH ) in the presence of different metal ions.
Journal ArticleDOI
Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Hao Peng,Lei Chen,Ling-Long Tang,Wen-Fei Li,Yan Ping Mao,Rui Guo,Yuan Zhang,Lizhi Liu,Li Tian,Xu Zhang,Xiao-Ping Lin,Ying Guo,Ying Sun,Jun Ma +13 more
TL;DR: PET/CT was more effective than MRI in identifying metastatic SCLNs, and the radiologic diagnostic criteria for metastatic lymph nodes in level IV/Vb should be re-defined.
Journal ArticleDOI
Sub-1 μm Free-Standing Symmetric Membrane for Osmotic Separations
TL;DR: In this paper, the internal concentration polarization (ICP) in osmotic separations, such as desalination and water purification, was investigated and shown to be a serious problem.
Journal ArticleDOI
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy
Shan Shan Guo,Lin Quan Tang,Lu Zhang,Qiu Yan Chen,Li Ting Liu,Ling Guo,Hao Yuan Mo,Dong Hua Luo,Pei Yu Huang,Yan Qun Xiang,Rui Sun,Ming Yuan Chen,Lin Wang,Xing Lv,Chong Zhao,Xiang Guo,Ka Jia Cao,Chao Nan Qian,Mu Sheng Zeng,Jin Xin Bei,Ming Huang Hong,Jian Yong Shao,Ying Sun,Jun Ma,Hai Qiang Mai +24 more
TL;DR: The cumulative dose of cisplatin is associated with OS and distant metastasis-free survival (DMFS) among NPC patients who received IMRT.
Journal ArticleDOI
Inhibition of bromate formation in the O3/PMS process by adding low dosage of carbon materials: Efficiency and mechanism
TL;DR: In this paper, a low dosage of powdered activated carbon (PAC), carbon nanotube (CNT) and graphene oxide (GO) was used in the inhibition of bromate formation and the enhanced degradation of organic pollutants during the O3/PMS process.